This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Helicobacter Pylori Infection
and you are
between 18 and 60
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Addition of L. reuteri to the standard triple therapy improves H. Pylori treatment outcomes.

Provided treatments

  • : Lactobacillus reuteri
  • : Placebo
  • Drug: Omeprazole
  • Drug: Amoxicillin
  • Drug: Clarithromycin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01593592. The sponsor of the trial is Zagazig University and it is looking for 70 volunteers for the current phase.
Official trial title:
Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients: a Double Blind Placebo Controlled Randomized Clinical Trial